Pharmaceutical Management and Health Economics
Core concepts
This domain covers pharmacy organisation, supply chain and economics. Candidates must understand inventory management (ABC analysis, economic order quantity, safety stock, stock rotation with FEFO - first-expiry-first-out), procurement and tendering, and the cold-chain requirements for temperature-sensitive medicines. Know the concept of the medicines reimbursement list and reference pricing, the difference between generic and originator pricing, and the principles of pharmacoeconomics: cost-minimisation, cost-effectiveness, cost-utility (QALY) and cost-benefit analysis. Understand the role of health technology assessment and the budget impact of new medicines, plus the pharmacy business model (dispensing margin, OTC sales, services). Know the principles of good distribution practice and traceability (batch recall, serialisation).
Traps
Questions test the difference between the four pharmacoeconomic analyses and their outcome measures (cost per QALY for cost-utility; cost per natural unit for cost-effectiveness). Another trap is confusing FEFO with FIFO, or assuming that a lower acquisition price always means lower total cost (ignoring holding, wastage and stock-out costs). Reimbursement questions test that the reference price is the maximum reimbursed amount, not the retail price.
Rule of thumb
For any economic evaluation question, identify the outcome measure first: money only → cost-minimisation; natural clinical units → cost-effectiveness; QALYs → cost-utility; monetary benefit → cost-benefit. For inventory, use FEFO for expiry-dated stock.
Worked example
Comparing two antihypertensives: drug A costs less but requires more monitoring visits; drug B costs more but has fewer adverse events. A cost-effectiveness analysis expresses the difference as cost per additional mm Hg reduction or per avoided event, allowing a like-for-like comparison rather than a simple price comparison.